Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s13181-014-0408-1 http://scihub22266oqcxt.onion/10.1007/s13181-014-0408-1 C4252285!4252285!24943229     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Med+Toxicol 2014 ; 10 (4): 406-10 Nephropedia Template TP {{tp|p=24943229|t=2014. Novel Use of Dexmedetomidine for the Treatment of Anticholinergic Toxidrome |pdf=|usr=}}{{24943229}} gab.com Text Novel Use of Dexmedetomidine for the Treatment of Anticholinergic Toxidrome JO: J Med Toxicol http://www.kidney.de/pget.php?&tw=1&pmid=24943229 #FOAvip Introduction: We report the case of an adolescent with anticholinergic toxidrome from diphenhydramine overdose, whose symptoms were treated with a novel application of dexmedetomidine. Case Report: A 13-year-old female developed an anticholinergic toxidrome after intentionally ingesting 9.5 mg/kg of diphenhydramine. Despite routine supportive therapies, to include appropriate doses of lorazepam, she continued to have significant agitation, psychosis, and hallucinations. A dexmedetomidine infusion was started to aid in the treatment of her agitation and psychosis with marked improvement of her symptoms. Discussion: Using dexmedetomidine for the treatment of anticholinergic toxidrome has not been previously described in the literature, but there are multiple reports of its use in alcohol withdrawal syndrome. We suggest that adding dexmedetomidine as an adjunctive agent in the therapy of anticholinergic toxidrome may relieve the symptoms of agitation, psychosis, tachycardia, and hypertension, without the attendant risk of respiratory depression associated with high doses of benzodiazepines. Twit Text FOAVip Novel Use of Dexmedetomidine for the Treatment of Anticholinergic Toxidrome ????J Med Toxicol http://www.kidney.de/pget.php?&tw=1&pmid=24943229 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24943229 #FOAvip English Wikipedia <ref>{{Cite pmid|24943229}}</ref> Novel Use of Dexmedetomidine for the Treatment of Anticholinergic Toxidrome #MMPMID24943229 Walker A; Delle Donne A; Douglas E; Spicer K; Pluim T J Med Toxicol 2014[Dec]; 10 (4): 406-10 PMID24943229show ga Introduction: We report the case of an adolescent with anticholinergic toxidrome from diphenhydramine overdose, whose symptoms were treated with a novel application of dexmedetomidine. Case Report: A 13-year-old female developed an anticholinergic toxidrome after intentionally ingesting 9.5 mg/kg of diphenhydramine. Despite routine supportive therapies, to include appropriate doses of lorazepam, she continued to have significant agitation, psychosis, and hallucinations. A dexmedetomidine infusion was started to aid in the treatment of her agitation and psychosis with marked improvement of her symptoms. Discussion: Using dexmedetomidine for the treatment of anticholinergic toxidrome has not been previously described in the literature, but there are multiple reports of its use in alcohol withdrawal syndrome. We suggest that adding dexmedetomidine as an adjunctive agent in the therapy of anticholinergic toxidrome may relieve the symptoms of agitation, psychosis, tachycardia, and hypertension, without the attendant risk of respiratory depression associated with high doses of benzodiazepines. äNovel Use of Dexmedetomidine for the Treatment of Anticholinergic Toxi(epmc).pdf DeepDyve Pubget Overpricing